Guangrong Zheng

机构：Kunming Medical University, University of Florida Health, University of Florida, Yunnan Center for Disease Control And Prevention, Drug Discovery Laboratory (Norway), Medicina, Yan'an Hospital Affiliated To Kunming Medical University, Florida College · ORCID：0000-0002-8106-6663

发表论文 244 篇 · 总被引 6508 次 · h-index 38

代表论文

First in human phase 1 study of DT2216, a selective BCL-xL degrader, in patients with relapsed/refractory solid malignancies (2025 · Journal of Hematology & Oncology · 被引 16)
Discovery of CRBN-recruiting PROTAC degraders of the METTL3-METTL14 complex (2025 · Medicinal Chemistry Research · 被引 8)
Targeting Lineage-Specific Functions of NR4A1 for Cancer Immunotherapy (2025 · International Journal of Molecular Sciences · 被引 8)
Nano-TPD: Using nanoparticle-based systems to improve the delivery and therapeutic effect of targeted protein degraders (2025 · Medicinal Chemistry Research · 被引 7)
Bacteria-based drug-loaded mesoporous silica nanoparticles for synergistic FUAS of breast cancer (2025 · Cancer Nanotechnology · 被引 5)
Abstract CT063: First in human phase 1 study of DT2216, a selective BCL-xL degrader, in patients with relapsed/refractory solid malignancies (NCT04886622) (2025 · Cancer Research · 被引 5)